The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to EMD Serono's investigational drug ...
A cutting-edge immunotherapy could help kids fight — and even banish — brain tumors, the leading cause of cancer-related ...
Morning Overview on MSN
A cell therapy for an aggressive childhood leukemia just won breakthrough status
Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
The FDA has granted breakthrough therapy designation to enpatoran for lupus with active skin manifestations, according to a ...
Add Yahoo as a preferred source to see more of our stories on Google. The latest FDA recognition is supported by positive results from several studies Novartis has announced that the US Food and Drug ...
Praxis Precision Medicines has received Breakthrough Therapy Designation (BTD) from the FDA for relutrigine, a sodium channel modulator intended for pediatric treatment of SCN2A and SCN8A ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Datopotamab deruxtecan (Dato-DXd) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of adult patients with locally ...
The Breakthrough Therapy Designation (BTD) was granted based on the positive results from the EMBRAVE Part A trial of elsunersen Elsunersen ...
Are you tired of feeling "stuck" in patterns that no longer serve you? Perhaps traditional therapy or medications haven't reached the root of your pain. At Breakthrough Therapy, we see you as a whole ...
First Breakthrough Therapy Designation for Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan based on TROPION-Lung05 phase 2 trial and supported by data from TROPION-Lung01 phase 3 trial Twelfth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results